Abstract
Osteoporosis is recognized as a major public health problem worldwide and in Taiwan. However, many patients with osteoporotic fractures do not receive appropriate assessments or treatments. This guideline, proposed by the Taiwanese Osteoporosis Association, is to serve as a quick reference for healthcare providers to improve the assessment of osteoporosis and development of optimal strategies for osteoporotic management in Taiwan. To review and update osteoporosis management, the guideline is constituted with Taiwan-specific osteoporosis epidemiological data, medication protocols, and the 10-year FRAX®. The guideline is based on evidence-based medicine and public health considerations. Recommendations are not limited to the reimbursement regulations permitted by the National Health Insurance of Taiwan.
Similar content being viewed by others
References
NIH Consensus Development Panel on Osteoporosis Prevention DaT (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882
Tsai K, Twu S, Chieng P, Yang R, Lee T (1996) Prevalence of vertebral fractures in Chinese men and women in urban Taiwanese communities. Calcif Tissue Int 59:249–253
Yang NP, Deng CY, Chou YJ, Chen PQ, Lin CH, Chou P, Chang HJ (2006) Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 75:329–337
Lin YC, Pan WH (2011) Bone mineral density in adults in Taiwan: results of the Nutrition and Health Survey in Taiwan 2005–2008 (NAHSIT 2005–2008). Asia Pac J Clin Nutr 20:283–291
Shao CJ, Hsieh YH, Tsai CH, Lai KA (2009) A nationwide seven-year trend of hip fractures in the elderly population of Taiwan. Bone (NY) 44:125–129
Ho CA, Li CY, Hsieh KS, Chen HF (2010) Factors determining the 1-year survival after operated hip fracture: a hospital-based analysis. J Orthop Sci 15:30–37
Kanis J, Johansson H, Odén A, McCloskey E (2012) The distribution of FRAX®-based probabilities in women from Japan. J Bone Miner Metab 30:700–705
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, et al (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:2395–2411
Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, Huang QR, Rajatanavin R, Tsai KS, Park HM, Reginster JY, Osteoporosis Self-Assessment Tool for Asians (OSTA) Research Group (2001) A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int 12:699–705
Green AD, Colon-Emeric CS, Bastian L, Drake MT, Lyles KW (2004) Does this woman have osteoporosis? JAMA 292:2890–2900
Genant HK, Wu CY, van KC, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148
Kung AW, Wu CH, Itabashi A, Lee JK, Park HM, Zhao Y, Chan WP, Kendler DL, Leib ES, Lewiecki EM, Bilezikian JP, Baim S, Asia Pacific Panel of ISCD (2010) International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus. J Clin Densitom 13:346–351
Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370:657–666
Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R, European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. [Erratum appears in Osteoporos Int 2008;19:1103–1104]. Osteoporos Int 19:399–428
Sinaki M (2007) The role of physical activity in bone health: a new hypothesis to reduce risk of vertebral fracture. Phys Med Rehabil Clin N Am 18:593–608
MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213
Oh K, Kim DY, Lee YS, Kang M (2012) Osteoporosis Patient Treatment Satisfaction Questionnaire in postmenopausal women intermittently treated with oral bisphosphonates: the BRAVO study. J Bone Miner Metab 30:359–366
Yen ML, Yen BL, Jang MH, Hsu SH, Cheng WC, Tsai KS (2000) Effects of alendronate on osteopenic postmenopausal Chinese women. Bone (NY) 27:681–685
Hwang JS, Tu ST, Yang TS, Chen JF, Wang CJ, Tsai KS (2006) Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis. Osteoporos Int 17:373–378
Hwang JS, Chen JF, Yang TS, Wu DJ, Tsai KS, Ho C, Wu CH, Su SL, Wang CJ, Tu ST (2008) The effects of strontium ranelate in Asian women with postmenopausal osteoporosis. [Erratum appears in Calcif Tissue Int 2009;84(4):334]. Calcif Tissue Int 83:308–314
Hwang JS, Chin LS, Chen JF, Yang TS, Chen PQ, Tsai KS, Leung PC (2011) The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis. J Bone Miner Metab 29:328–333
Hwang JS, Liou MJ, Ho C, Lin JD, Huang YY, Wang CJ, Tsai KS, Chen JF (2010) The effects of weekly alendronate therapy in Taiwanese males with osteoporosis. J Bone Miner Metab 28:328–333
Lin TC, Yang CY, Yang YH, Lin SJ (2011) Alendronate adherence and its impact on hip-fracture risk in patients with established osteoporosis in Taiwan. Clin Pharmacol Ther 90:109–116
Tseng LN, Sheu WH, Ho ES, Lan HH, Hu CC, Kao CH (2006) Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women. Metab Clin Exp 55:741–747
Woo SB, Hellstein JW, Kalmar JR (2006) Narrative review: bisphosphonates and osteonecrosis of the jaws. [Erratum appears in Ann Intern Med 2006;145(3):235]. Ann Intern Med 144:753–761
Hsiao FY, Huang WF, Chen YM, Wen YW, Kao YH, Chen LK, Tsai YW (2011) Hip and subtrochanteric or diaphyseal femoral fractures in alendronate users: a 10-year, nationwide retrospective cohort study in Taiwanese women. Clin Ther 33:1659–1667
Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. [Erratum appears in N Engl J Med 2011;365(16):1551]. N Engl J Med 364:1728–1737
Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62:1515–1526
Conflict of interest
All authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
J.-S. Hwang and D.-C. Chan contributed equally to this work.
About this article
Cite this article
Hwang, JS., Chan, DC., Chen, JF. et al. Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary. J Bone Miner Metab 32, 10–16 (2014). https://doi.org/10.1007/s00774-013-0495-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-013-0495-0